Shenzhen People' hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2017
NCT04426422
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Department of Cardiology, Shenzhen People's Hospital, Shenzhen 518020, Guangdong, China | Shenzhen People' hospital

Active Ingredients

Drugs in Phase 4 Trials (1)

metformin (glucophage) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1